The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
Open accessPublished version of a preprint
Abstract
Cancer-associated fibroblasts enhance cancer progression when activated by tumor cells through mechanisms not yet fully understood. Blocking mammary tumor cell–derived lysyl oxidase-like 2 (LOXL2) significantly inhibited mammary tumor cell invasion and metastasis in transgenic and orthotopic mouse models. Here, we discovered that tumor-derived LOXL2 directly activated stromal fibroblasts in the tumor microenvironment. Genetic manipulation or antibody inhibition of LOXL2 in orthotopically grown mammary tumors reduced the expression of α-smooth muscle actin (α-SMA). Using a marker for reticular fibroblasts, it was determined that expression of α-SMA was localized to fibroblasts recruited from the host tissue. This marker also revealed that the matrix present in tumors with reduced levels of LOXL2 was more scattered compared with control tumors which exhibited matrices with dense, parallel alignments. Importantly, in vitro assays revealed that tumor-derived LOXL2 and a recombinant LOXL2 protein induced fibroblast branching on collagen matrices, as well as increased fibroblast-mediated collagen contraction and invasion of fibroblasts through extracellular matrix. Moreover, LOXL2 induced the expression of α-SMA in fibroblasts grown on collagen matrices. Mechanistically, it was determined that LOXL2 activated fibroblasts through integrin-mediated focal adhesion kinase activation. These results indicate that inhibition of LOXL2 in tumors not only reduces tumor cell invasion but also attenuates the activation of host cells in the tumor microenvironment. Implications: These findings reveal new insight into the mechanisms of fibroblast activation, a novel function of LOXL2, and further highlight the importance of generating LOXL2-targeted therapies for the prevention of tumor progression and metastasis. Mol Cancer Res; 11(11); 1425–36. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, CAFs secrete a plethora of soluble and ECM-associated factors, including cytokines, chemokines and growth factors that promote tumor growth and cancer cell dissemination40,240.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedCalcium's Role in Mechanotransduction during Muscle Development
Damm, T. B., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,552
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,857
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Self-citationOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Focal adhesion kinase: in command and control of cell motility
Mitra, S. K., Hanson, D. A., & Schlaepfer, D. D. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1549 · Cited by 2,657
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,350
Research works printed but not linked: 1
- Tarin, 1969, Ultrastructural features of wound healing in mouse skin, J Anat, 105, 189
Cited by
Sorted by citations
FAK in cancer: mechanistic findings and clinical applications
Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins
Zeltz, C., Primac, I., Erusappan, P., Alam, J., Noel, A., & Gullberg, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.004 · Cited by 290
Targeting ECM Disrupts Cancer Progression
Venning, F. A., Wullkopf, L., & Erler, J. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00224 · Cited by 256
Self-citationTissue Force Programs Cell Fate and Tumor Aggression
Northey, J. J., Przybyla, L., & Weaver, V. M. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0733 · Cited by 242
Emerging Roles of Focal Adhesion Kinase in Cancer
Tai, Y.-L., Chen, L., & Shen, T. (2015) · BioMed Research International · doi:10.1155/2015/690690 · Cited by 226
Melanoma miRNA trafficking controls tumour primary niche formation
Dror, S., Sander, L., Doron, H., Sheinboim, D., Barzilai, A., Dishon, Y., Apcher, S., Golan, T., Greenberger, S., Barshack, I., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3399 · Cited by 214
Peng, D. H., Ungewiss, C., Tong, P., Byers, L. A., Wang, J., Canales, J. R., Villalobos, P. A., Uraoka, N., Mino, B., Behrens, C., et al. (2016) · Oncogene · doi:10.1038/onc.2016.358 · Cited by 211
Sharon, Y., Raz, Y., Cohen, N., Ben‐Shmuel, A., Doron, H., Geiger, T., & Erez, N. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1990 · Cited by 175
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
Madsen, C. D., Pedersen, J. T., Venning, F. A., Singh, L. B., Moeendarbary, E., Charras, G., Cox, T. R., Sahai, E., & Erler, J. T. (2015) · The EMBO Reports · doi:10.15252/embr.201540107 · Cited by 157
Self-citationMoon, H.-J., Finney, J., Ronnebaum, T. A., & Mure, M. (2014) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2014.07.003 · Cited by 138
Grossman, M., Ben‐Chetrit, N., Zhuravlev, A., Afik, R., Bassat, E., Solomonov, I., Yarden, Y., & Sagi, I. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2813 · Cited by 134
Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis
Aumiller, V., Strobel, B., Romeike, M., Schuler, M. J., Stierstorfer, B., & Kreuz, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00270-0 · Cited by 136
de Jong, O. G., van Balkom, B. W. M., Gremmels, H., & Verhaar, M. C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12730 · Cited by 135
Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer
Trackman, P. C. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1151003 · Cited by 133
Schilter, H. C., Findlay, A. D., Perryman, L., Yow, T. T., Moses, J., Zahoor, A., Turner, C. I., Deodhar, M., Foot, J. S., Zhou, W., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14074 · Cited by 118
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Chang, J., Lucas, M. C., Leonte, L. E., García-Montolio, M., Singh, L. B., Findlay, A. D., Deodhar, M., Foot, J. S., Jarolimek, W., Timpson, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15257 · Cited by 113
Self-citationLOXL2 in cancer: regulation, downstream effectors and novel roles
Wen, B., Xu, L., & Li, E. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188435 · Cited by 113
Setargew, Y. F. I., Wyllie, K., Grant, R. D., Chitty, J. L., & Cox, T. R. (2021) · Cancers · doi:10.3390/cancers13030491 · Cited by 114
The hallmarks of CAFs in cancer invasion
Atieh, Y., & Vignjevic, D. M. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.07.004 · Cited by 118
Nguyen, E. V., Pereira, B. A., Lawrence, M. G., Ma, X., Rebello, R. J., Chan, H., Niranjan, B., Wu, Y., Ellem, S., Guan, X., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001496 · Cited by 107
Zaghdoudi, S., Decaup, E., Belhabib, I., Samain, R., Cassant‐Sourdy, S., Rochotte, J., Brunel, A., Schlaepfer, D. D., Cros, J. F., Neuzillet, C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012010 · Cited by 109
Emerging Roles of Extracellular Hsp90 in Cancer
Wong, D. S., & Jay, D. G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.001 · Cited by 99
Martín, A. L., Salvador, F., Moreno‐Bueno, G., Floristán, A., Ruiz‐Herguido, C., Cuevas, E. P., Morales, S., Santos, V., Csiszár, K., Dubus, P. R., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489975 · Cited by 93
Lahav, T. G., Adler, O., Zait, Y., Shani, O., Amer, M., Doron, H., Abramovitz, L., Yofe, I., Cohen, N., & Erez, N. (2019) · International Journal of Cancer · doi:10.1002/ijc.32521 · Cited by 92
Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy
Ye, M., Song, Y., Pan, S., Chu, M., Wang, Z. P., & Zhu, X. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107633 · Cited by 89
Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression
Liburkin-Dan, T., Toledano, S., & Neufeld, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116249 · Cited by 88
Cortés, E., Lachowski, D., Robinson, B. K., Sarper, M., Teppo, J., Thorpe, S. D., Lieberthal, T. J., Iwamoto, K., Lee, D. A., Okada, M., et al. (2018) · EMBO Reports · doi:10.15252/embr.201846557 · Cited by 84
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
Kasashima, H., Yashiro, M., Kinoshita, H., Fukuoka, T., Morisaki, T., Masuda, G., Sakurai, K., Kubo, N., Ohira, M., & Hirakawa, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.014 · Cited by 82
Zhang, Q., An, Z.-Y., Jiang, W. G., Jin, W., & He, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115390 · Cited by 79
Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
Amendola, P. G., Reuten, R., & Erler, J. T. (2019) · Cancers · doi:10.3390/cancers11050729 · Cited by 76
Self-citationFibroblast activation and heterogeneity in fibrotic disease
Zhang, X., Zhang, Y., & Liu, Y. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-00969-8 · Cited by 82
Proteomic landscape of the extracellular matrix in the fibrotic kidney
Li, L., He, M., Tang, X., Huang, J., Li, J., Hong, X., Fu, H., & Liu, Y. (2023) · Kidney International · doi:10.1016/j.kint.2023.01.021 · Cited by 74
Nilsson, M., Adamo, H. H., Bergh, A. R. J., & Bergström, S. H. (2016) · Scientific Reports · doi:10.1038/srep19608 · Cited by 66
Lysyl Oxidase Family Proteins: Prospective Therapeutic Targets in Cancer
Wang, W., Wang, X., Yao, F., & Huang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012270 · Cited by 63
Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
Park, J. S., Lee, J.-H., Lee, Y. S., Kim, J. K., Dong, S. M., & Yoon, D. S. (2016) · Oncotarget · doi:10.18632/oncotarget.9918 · Cited by 58
Dinca, S. C., Greiner, D., Weidenfeld, K., Bond, L., Barkan, D., & Jorcyk, C. L. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01430-x · Cited by 58
Stroma as an Active Player in the Development of the Tumor Microenvironment
Vannucci, L. E. (2014) · Cancer Microenvironment · doi:10.1007/s12307-014-0150-x · Cited by 56
Lysyl oxidases: linking structures and immunity in the tumor microenvironment
Tenti, P., & Vannucci, L. E. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02404-x · Cited by 55
Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment
Giorello, M. B., Borzone, F. R., Labovsky, V., Piccioni, F., & Chasseing, N. A. (2021) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-020-09475-y · Cited by 58
Hypoxic Signalling in Tumour Stroma
Laitala, A., & Erler, J. T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00189 · Cited by 55
Self-citationTargeting cancer-associated fibroblasts: Challenges, opportunities and future directions
Jenkins, B. H., Buckingham, J. F., Hanley, C. J., & Thomas, G. J. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108231 · Cited by 55
Lysyl Oxidase in Cancer Research
Perryman, L., & Erler, J. T. (2014) · Future Oncology · doi:10.2217/fon.14.39 · Cited by 53
Self-citationFocal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression
Rigiracciolo, D. C., Cirillo, F., Talia, M., Muglia, L., Gutkind, J. S., Maggiolini, M., & Lappano, R. (2021) · Cancers · doi:10.3390/cancers13040645 · Cited by 55
Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment
Xiong, Y. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.253 · Cited by 51
Wang, C., Xu, S., Tian, Y., Ju, A., Hou, Q., Liu, J., Fu, Y., & Luo, Y. (2019) · Neoplasia · doi:10.1016/j.neo.2019.03.003 · Cited by 48
Gharib, A. M., Han, M. A. T., Meissner, E. G., Kleiner, D. E., Zhao, X., McLaughlin, M. E., Matthews, L., Rizvi, B., Abd‐Elmoniem, K. Z., Sinkus, R., et al. (2017) · BioMed Research International · doi:10.1155/2017/2067479 · Cited by 44
Umaña-Diaz, C., Pichol-Thievend, C., Marchand, M. F., Atlas, Y., Salza, R., Malbouyres, M., Barret, A., Teillon, J., Ardidie‐Robouant, C., Ruggiero, F., et al. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.11.003 · Cited by 44
Mechanobiology of Cancer Stem Cells and Their Niche
Choudhury, A. R., Gupta, S., Chaturvedi, P. K., Kumar, N., & Pandey, D. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00222-4 · Cited by 43
Lv, G.-Q., Zou, H., Liao, L., Cao, H., Zeng, F., Wu, B., Xie, J., Fang, W., Xu, L., & Li, E. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0046 · Cited by 40
Stangenberg, S., Saad, S., Schilter, H. C., Zaky, A. A., Gill, A. J., Pollock, C. A., & Wong, M. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-27462-6 · Cited by 42
LOXL2 in Cancer: A Two-Decade Perspective
Cano, A., Eraso, P., Mazón, M. J., & Portillo, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814405 · Cited by 40
Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity
Okada, K., Moon, H.-J., Finney, J., Meier, A. A., & Mure, M. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01008 · Cited by 36
Qiao, M., Zhou, F., Liu, X., Jiang, T., Wang, H., Li, X., Zhao, C., Cheng, L., Chen, X., Ren, S., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00471-6 · Cited by 35
Wen, X., Liu, Y., Bai, Y. Z., Li, M., Fu, Q., & Zheng, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3927 · Cited by 32
Lu, X., Xin, D. E., Du, J. K., Zou, Q. C., Wu, Q. Y., Zhang, Y. S., Deng, W., Yue, J., Fan, X. S., Zeng, Y., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0848 · Cited by 32
Skhinas, J. N., & Cox, T. R. (2017) · Cell Adhesion & Migration · doi:10.1080/19336918.2017.1405208 · Cited by 31
Xuefeng, X., Hou, M., Yang, Z., Agudamu, A., Wang, F., Su, X., Li, X., Shi, L., Terigele, T., Bao, L., et al. (2020) · Journal of International Medical Research · doi:10.1177/0300060520931242 · Cited by 30
Lysyl Oxidase Like‐2 (LOXL2): An Emerging Oncology Target
Chopra, V., Sangarappillai, R. M., Romero‐Canelón, I., & Jones, A. M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900119 · Cited by 25
Radić, J., Kožik, B., Nikolić, I., Kolarov-Bjelobrk, I., Vasiljević, T., Vranjković, B., & Despotović, S. Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411745 · Cited by 23
Targeting cancer metastasis with antibody therapeutics
Hui-lin, Y., Kuo, Y., Smith, Z., & Spangler, J. B. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1698 · Cited by 22
Clinical relevance of lysyl oxidase-like 2 and functional mechanisms in glioma
Du, X., & Zhu, M.-J. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s164056 · Cited by 22
Hong, X., & Yu, J. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4726 · Cited by 20
Choi, S., Jeon, N., Choi, H. Y., Shin, J. I., Jeong, H. J., & Lim, B. J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6918 · Cited by 19
Ribeiro, A. L., Kaid, C., Silva, P. B. G., Cortez, B. A., & Okamoto, O. K. (2017) · Stem Cells International · doi:10.1155/2017/4972078 · Cited by 18
Li, W., Xiong, L., Shi, X., Liang, X., QI, G.-Y., & MENG, C. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3054 · Cited by 17
Desa, D. E., Wu, W., Brown, R. M., Brown, E. B., Hill, R. L., Turner, B. M., & Brown, E. B. (2022) · Cancers · doi:10.3390/cancers14040857 · Cited by 16
CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Wang, Y., Hu, W., Xia, R., Yang, X., Gu, Y., Ning, Z., Yang, T., Yu, C., Zhang, L., Li, D., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.042 · Cited by 14
Biophysical perspectives to understanding cancer-associated fibroblasts
Devarasou, S., Kang, M., & Shin, J. H. (2024) · APL Bioengineering · doi:10.1063/5.0199024 · Cited by 12
The role of the LOX family in cancer
Boaru, D. L., León-Oliva, D. D., Fraile‐Μartinez, O., Castro-Martinez, P. D., Montero, C. G., Ferrara-Coppola, C., Alhaddadin, M. N. M., Barrena-Blázquez, S., Peñas-González, C. D. L., Holgado-Tirado, N., et al. (2025) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2025.151527 · Cited by 13
A 3D–Predicted Structure of the Amine Oxidase Domain of Lysyl Oxidase–Like 2
Meier, A. A., Kuczera, K., & Mure, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113385 · Cited by 12
A Comprehensive Review of Protein Biomarkers for Invasive Lung Cancer
Mezentsev, A., Durymanov, M. O., & Макаров, В. А. (2024) · Current Oncology · doi:10.3390/curroncol31090360 · Cited by 11
Bharti, A., Urs, A. B., & Kumar, P. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.2.341 · Cited by 11
Exposure to oxLDL impairs TGF-β activity in human tendon cells
Mousavizadeh, R., Waugh, C., DeBruin, E., McCormack, R. G., Duronio, V., & Scott, A. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06308-x · Cited by 9
Kielosto, M., Eriksson, J., Nummela, P., Yin, M., & Hölttä, E. (2018) · Oncotarget · doi:10.18632/oncotarget.26508 · Cited by 9
Ye, C., Jiang, S., Zeng, T., He, S., Cao, J., & Xiao, J. (2024) · Discover Oncology · doi:10.1007/s12672-024-01107-9 · Cited by 8
Bui, C., To, K. D., Vu, D. M., Nguyen, Q.-G., Nguyen, H. T., & Nguyen, S.-B. (2023) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2023.103624 · Cited by 8
Circulating tumor cells and the metastatic process: the complexity of malignancy
Raimo, T. D., Santis, E. D., Coppola, L., D'Andrea, M. R., & Angelini, F. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.50 · Cited by 7
Kim, H. S., Yun Sun, L. E. E., Dong, S. M., Kim, H. J., Lee, D. E., Kang, H. W., KIM, M. J., & Park, J. S. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.044029 · Cited by 7
Oxidative stress and copper smelter workers
Malekırad, A. A., Hassani, S., & Abdollahi, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819092-0.00013-3 · Cited by 6
Liburkin-Dan, T., Nir-Zvi, I., Razon, H., Kessler, O., & Neufeld, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911322 · Cited by 5
Premetastatic niche mechanics and organotropism in breast cancer
Libring, S., & Reinhart‐King, C. A. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-025-00015-5 · Cited by 5
Xu, X., & Wang, J. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1088091 · Cited by 5
FAK Differentially Mechanoregulates Cell Migration during Wound Closure
Patten, J., Albeltagy, N., Bonadio, J. D., Ortez, A., & Wang, K. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c00667 · Cited by 4
Liu, H., Sun, X., Dong, B., Zhang, J., Zhang, J., Gu, Y., Chen, L., Pang, X., Ye, J., Wang, X., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70536 · Cited by 4
Molecular and Cellular Mechanobiology of Cancer
Fattet, L., & Yang, J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-5617-3_13 · Cited by 3
Correction: Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
(2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0860 · Cited by 3
Integrins in Cancer: Refocusing on the Tumor Microenvironment
Zeltz, C., Lü, N., Heljäsvaara, R., & Gullberg, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_11 · Cited by 3
Dinca, S. C., Greiner, D., Weidenfeld, K., Bond, L., Barkan, D., & Jorcyk, C. L. (2020) · Research Square · doi:10.21203/rs.3.rs-57684/v1 · Cited by 2
Song, C., Lin, Y., Cai, C., Tao, K., Tan, J., Xiong, K., Yang, W., Chi, J., Peng, Z., Zhao, G., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03466-1 · Cited by 1
Yang, S., Zhang, Q., Ran, Y., & Pan, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-30923-4 · Cited by 1
Feng, Y., Gu, L., Jia, Z., Zhang, C., & Zhu, Z. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1866753 · Cited by 1
Cross‐Talk Between Hypoxia and the Tumour via Exosomes
Sharma, S., Alharbi, M. G., Lai, A., Kobayashi, M., KLINE, R. C., Wade, K., Rice, G. E., & Salomón, C. (2017) · InTech eBooks · doi:10.5772/65688
Signaling Functions of Extracellular Hsp90 (eHsp90) in Cancer Metastasis
Bernstein, A., & Jay, D. G. (2019) · Heat shock proteins · doi:10.1007/978-3-030-03952-3_17 · Cited by 1
Findlay, A. D., Turner, C. I., & Hamprecht, D. W. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00145 · Cited by 1
Microenvironmental Control of Metastatic Progression
Roskelley, C. D. (2014) · Cancer metastasis · doi:10.1007/978-3-319-12136-9_6
Understanding of ‘Networks’ In Vitro and/or In Vivo
Schoof, E. M., Ferkinghoff‐Borg, J., & Linding, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.40027-1
Proteomic Signatures of the Colorectal Cancer Desmoplastic Invasion Front
Karagiannis, G. (2014) · TSpace (University of Toronto)
Epidemiological and molecular features of cutaneous squamous cell carcinoma with perineural spread
Warren, T. A. (2017) · The University of Queensland · doi:10.14264/uql.2017.1054
Eckardt, J. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8263
Metadata
- Authors
- Barker, H. E., Bird, D., Lang, G., & Erler, J. T.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Erler, Janine T.
- Venue
- Molecular Cancer Research
- Published
- 2013-11-01
- Volume
- 11
- Issue
- 11
- Pages
- 1425-1436
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- PMC
- PMC3833835
- OpenAlex
- W2105524728
- Cited by
- 119
- References
- 52
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 15 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 10 · 2019: 13 · 2018: 9 · 2017: 10 · 2016: 11 · 2015: 8 · 2014: 8
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-10-01)
- Open access
- green
- europepmc.org
- Locations
- Molecular Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Cancer Research UK (A11355, A10433)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- LOXL2, cancer-associated fibroblasts, fibroblast activation, focal adhesion kinase, integrin signaling, tumor microenvironment, mammary tumors, tumor invasion, metastasis, alpha-smooth muscle actin, collagen matrix, extracellular matrix remodeling
- MeSH terms
- Actins, Amino Acid Oxidoreductases, Animals, Cell Adhesion, Collagen, Extracellular Matrix, Female, Fibroblasts, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neoplasm Invasiveness, Signal Transduction, Gene Expression Regulation, Neoplastic, 3T3 Cells, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Kinase 1, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review